Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 99.
41. lappuse
... unit in- tended for administration directly from that container , irrespective of whether the recommended dose is one or more than one of these units . The term " dosage unit " means the individ- ual physical unit of the product , e.g. ...
... unit in- tended for administration directly from that container , irrespective of whether the recommended dose is one or more than one of these units . The term " dosage unit " means the individ- ual physical unit of the product , e.g. ...
229. lappuse
... units of bacitracin in a suitable ointment base : Provided , That it meets the tests and methods of assay in § 448.510a ( b ) . ( b ) Bacitracin zinc ointment contain- ing , in each gram , 500 units of baci- tracin zinc in a suitable ...
... units of bacitracin in a suitable ointment base : Provided , That it meets the tests and methods of assay in § 448.510a ( b ) . ( b ) Bacitracin zinc ointment contain- ing , in each gram , 500 units of baci- tracin zinc in a suitable ...
230. lappuse
... units of bacitracin and 3.5 milligrams of neomycin in a suitable ointment base : Provided , That it meets the tests ... units of bacitracin , 3 milli- grams of neomycin , and 8,000 units of polymyxin B ; or ( ii ) 400 units of bacitracin ...
... units of bacitracin and 3.5 milligrams of neomycin in a suitable ointment base : Provided , That it meets the tests ... units of bacitracin , 3 milli- grams of neomycin , and 8,000 units of polymyxin B ; or ( ii ) 400 units of bacitracin ...
231. lappuse
... units of bacitracin , 3 milli- grams of neomycin , 8,000 units of poly- myxin B , and any single generally rec- ognized as safe and effective amine or " caine " -type local anesthetic active ingredient ; or ( ii ) 400 units of ...
... units of bacitracin , 3 milli- grams of neomycin , 8,000 units of poly- myxin B , and any single generally rec- ognized as safe and effective amine or " caine " -type local anesthetic active ingredient ; or ( ii ) 400 units of ...
258. lappuse
... units of vitamin A and 400 U.S.P. units of cholecalciferol . ( 4 ) Zinc oxide not to exceed 25 per- cent by weight per dosage unit . § 346.16 Analgesic , anesthetic , antipruritic active ingredients . and The active ingredient of the ...
... units of vitamin A and 400 U.S.P. units of cholecalciferol . ( 4 ) Zinc oxide not to exceed 25 per- cent by weight per dosage unit . § 346.16 Analgesic , anesthetic , antipruritic active ingredients . and The active ingredient of the ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning